iBio, Inc.
IBIO
$1.25
-$0.02-1.19%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -79.81% | -31.51% | -28.15% | 13.14% | 26.22% |
| Total Depreciation and Amortization | -8.53% | -5.08% | -6.80% | -6.19% | -9.92% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 327.38% | -0.75% | -27.99% | -82.59% | -81.99% |
| Change in Net Operating Assets | 426.51% | 36.86% | 146.30% | 112.18% | 115.12% |
| Cash from Operations | -51.71% | -39.00% | -15.75% | -1.92% | 17.52% |
| Capital Expenditure | -3,512.50% | -148.89% | -166.82% | 77.14% | 92.38% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4,245.25% | -3,889.61% | -1,494.98% | -1,350.20% | -24.20% |
| Cash from Investing | -4,412.53% | -5,080.47% | -1,659.99% | -1,468.01% | -18.10% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -11.37% | 45.35% | 34.20% | 58.47% | 65.81% |
| Issuance of Common Stock | 907.63% | -10.69% | -59.05% | -82.43% | -85.73% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1,022.68% | 89,720.45% | 66,282.95% | 59,751.14% | 6,863.64% |
| Cash from Financing | 1,054.08% | 568.25% | 265.66% | 155.24% | -63.55% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 949.12% | 3,516.89% | 581.62% | 162.74% | -182.28% |